NewsGSK Reports the US FDA’s NDA Acceptance of Linerixibat for Primary Biliary Cholangitis (PBC) Patients with Cholestatic PruritusByRidhi RastogiJune 2, 20250Comments
NewsAstraZeneca Presents P-III (MATTERHORN) Trial Data of Imfinzi as Perioperative Therapy for G/GEJ Cancers at ASCO 2025ByRidhi RastogiJune 2, 20250Comments
NewsKura Oncology and Kyowa Kirin Report the US FDA’s NDA Acceptance and Priority Review of Ziftomenib for Acute Myeloid LeukemiaByRidhi RastogiJune 2, 20250Comments
Weekly SnapshotPharmaShots Weekly Snapshots (May 26, 2025 – May 30, 2025) ByRidhi RastogiMay 30, 20250Comments
NewsCoreMap Reports the US FDA’s IDE Approval for CoreMap’s EP Map-Guided AF Ablation StudyByRidhi RastogiMay 30, 20250Comments
NewsZymeworks’ Zanidatamab Receives the NMPA’s Conditional Approval for the Treatment of Biliary Tract CancerByRidhi RastogiMay 30, 20250Comments
NewsReflow Medical’s Spur Peripheral Retrievable Stent System Receives the US FDA’s De Novo Clearance for BTK-CLTI TreatmentByRidhi RastogiMay 30, 20250Comments
